28 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
12639555	10	Synthesis and anti-influenza evaluation of orally active bicyclic ether derivatives related to zanamivir.	Sankyo
12113810	20	Synthesis and anti-influenza virus activity of 7-O-alkylated derivatives related to zanamivir.	Sankyo
12113809	12	Synthesis and anti-influenza virus activity of 4-guanidino-7-substituted Neu5Ac2en derivatives.	Sankyo
22677529	3	Pyrrolidinobenzoic acid inhibitors of influenza virus neuraminidase: the hydrophobic side chain influences type A subtype selectivity.	University Of Alabama At Birmingham
18694948	17	Limited inhibitory effects of oseltamivir and zanamivir on human sialidases.	Miyagi Cancer Center Research Institute
15214773	76	Fragment-based drug discovery.	Sunesis Pharmaceuticals
11000002	10	BCX-1812 (RWJ-270201): discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design.	Biocryst Pharmaceuticals
10602699	15	Binding constants of neuraminidase inhibitors: An investigation of the linear interaction energy method.	University Of Southampton
9526556	18	Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 2. Crystallographic and molecular modeling study of complexes of 4-amino-4H-pyran-6-carboxamides and sialidase from influenza virus types A and B.	Glaxo Wellcome Research And Development
8126701	3	Molecular modeling studies on ligand binding to sialidase from influenza virus and the mechanism of catalysis.	Monash University
11266166	36	Sialidase inhibitors related to zanamivir. Further SAR studies of 4-amino-4H-pyran-2-carboxylic acid-6-propylamides.	Glaxowellcome Medicines Research Centre
	22	Novel inhibitors of influenza sialidases related to zanamivir. Heterocyclic replacements of the glycerol sidechain	TBA
	51	Novel inhibitors of influenza sialidases related to GG167 structure-activity, crystallographic and Molecular dynamics studies with 4H-pyran-2-carboxylic acid 6-carboxamides	TBA
	16	Novel inhibitors of influenza sialidase related to GG167 Synthesis of 4-amino and guanidino-4H-pyran-2-carboxylic acid-6-propylamides; selective inhibitors of influenza a virus sialidase	TBA
22100261	12	Synthesis and biological evaluation of sialic acid derivatives containing a long hydrophobic chain at the anomeric position and their C-5 linked polymers as potent influenza virus inhibitors.	Saitama University
21843936	35	3D QSAR and docking study of flavone derivatives as potent inhibitors of influenza H1N1 virus neuraminidase.	Chinese Academy Of Medical Sciences
20014777	6	Antiviral potential and molecular insight into neuraminidase inhibiting diarylheptanoids from Alpinia katsumadai.	University Of Innsbruck
15828835	6	Dimeric zanamivir conjugates with various linking groups are potent, long-lasting inhibitors of influenza neuraminidase including H5N1 avian influenza.	Glaxosmithkline
15582424	6	Design, synthesis, and structural analysis of inhibitors of influenza neuraminidase containing a 2,3-disubstituted tetrahydrofuran-5-carboxylic acid core.	Abbott Laboratories
11312919	22	Design, synthesis, and structural analysis of influenza neuraminidase inhibitors containing pyrrolidine cores.	Abbott Laboratories
10395473	19	Potent inhibition of influenza sialidase by a benzoic acid containing a 2-pyrrolidinone substituent.	University Of Alabama At Birmingham
16621549	40	Novel 5-azaindole factor VIIa inhibitors.	Celera
14561087	27	Structure-activity relationships of the p38alpha MAP kinase inhibitor 1-(5-tert-butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-[4-(2-morpholin-4-yl-ethoxy)naph- thalen-1-yl]urea (BIRB 796).	Boehringer Ingelheim Pharmaceuticals
11896401	3	Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site.	Boehringer Ingelheim Pharmaceuticals
15857116	5	1-(5-Chloro-2-alkoxyphenyl)-3-(5-cyanopyrazin-2-yl)ureas [correction of cyanopyrazi] as potent and selective inhibitors of Chk1 kinase: synthesis, preliminary SAR, and biological activities.	Abbott Laboratories
16303309	31	Bicyclic and tricyclic thiophenes as protein tyrosine phosphatase 1B inhibitors.	Wyeth Research
10694412	15	Thermodynamics of substrate binding to the chaperone SecB.	Indian Institute Of Science